Bay Street News, December, 2018

Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S. CARLSBAD, Calif., Dec. 26, 2018 […]

Partnership Involves Large-Scale Production of CL2A-SN-38, the Drug-Linker Used in Immunomedics’ Lead Antibody-Drug Conjugate, Sacituzumab Govitecan MORRIS PLAINS, N.J. and […]

DALLAS and FORT WORTH, Texas, Dec. 26, 2018 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on […]

Adjusted Vectra Test Is Up to Five Times More Effective for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis than […]

Monaco, Dec. 26, 2018 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog”) (NYSE:GLOG) is pleased to announce that, as referenced in the […]

BUFFALO, N.Y., Dec. 26, 2018 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development […]

BEIJING, Dec. 26, 2018 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD), China’s leading technology driven e-commerce company and retail infrastructure service […]

BrainStorm has contracted with the Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute, currently supporting the […]

VANCOUVER, British Columbia, Dec. 24, 2018 (GLOBE NEWSWIRE) — Goldstrike Resources Ltd. (GSR.V) is pleased to report that Terrence King, […]

LONDON, Dec. 24, 2018 (GLOBE NEWSWIRE) — VivoPower International PLC (“VivoPower”, the “Company”), an international solar power company, today announced […]